Role of single nucleotide polymorphisms and haplotypes in BRCA1 in breast cancer: Czech case-control study

Breast Cancer Research and Treatment

Volumn 103, Issue 2, 2007, Pages 219-224

  Soucek, P ^a   Borovanova, T ^a   Pohlreich, P ^b   Kleibl, Z ^b   Novotny, J ^c  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

BRCA1; Breast; Cancer; Haplotypes; Pathology; Polymorphisms; Prognosis; Risk

Indexed keywords

BRCA1 PROTEIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CODON; CONFIDENCE INTERVAL; CONTROLLED STUDY; CZECH REPUBLIC; FEMALE; GENE FREQUENCY; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PATHOLOGY; POPULATION BASED CASE CONTROL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENES, BRCA1; HAPLOTYPES; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34249001692     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9367-9     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, et al (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106-130
2. Miki Y, Swensen J, Shattuck-Eidens D, et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
3. Wooster R, Neuhausen SL, Mangion J, et al (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090
4. Chen CF, Li S, Chen Y, Chen PL, Sharp ZD, Lee WH (1996) The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor. J Biol Chem 271:32863-32868
5. Wilson CA, Ramos L, Villasenor MR, et al (1999) Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet 21:236-240
6. ElShamy WM, Livingston DM (2004) Identification of BRCA1-IRIS, a BRCA1 locus product. Nat Cell Biol 6:954-967
7. Deng CX. (2006) BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res, 34:1416-1426
8. Koonin EV, Altschul SF, Bork P. (1996) BRCA1 protein products ... Functional motifs... Nat Genet 13:266-268
9. Callebaut I, Mornon JP (1997) From BRCA 1 to RAP 1: a widespread BRCT module closely associated with DNA repair. FEBS Lett 400:25-30
10. Chapman MS, Verma IM (1996) Transcriptional activation by BRCA1. Nature 382:678-679
11. Scully R, Anderson SF, Chao DM, et al (1997) BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci USA 94:5605-5610
12. Welcsh PL, Owens KN, King MC (2000) Insights into the functions of BRCA1 and BRCA2. Trends Genet 16:69-74
13. Monteiro AN, Humphrey JS. (1998) Yeast-based assays for detection and characterization of mutations in BRCA1. Breast Dis 10:61-70
14. Abeliovich D, Kaduri L, Lerer I, et al (1997) The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet 60:505-514
15. Soucek P, Gut I, Trneny M, et al (2003) Multiplex single-tube screening for mutations in the Nijmegen Breakage Syndrome (NBS1) gene in Hodgkin's and non-Hodgkin's lymphoma patients of Slavic origin. Eur J Hum Genet 11:416-419
16. Walsh T, Casadei S, Coats KH, et al (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295:1379-1388
17. Sugimura H, Caporaso NE, Shaw GL, et al (1990). Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls. Carcinogenesis 11:1527-1530
18. Dupont WD, Plummer WD (1997) PS power and sample size program available for free on the Internet. Control Clin Trials 1:274
19. Durocher F, Shattuck-Eidens D, McClure M, et al (1996) Comparison of BRCA 1 polymorphisms, rare sequence variants and-or missense mutations in unaffected and breast-ovarian cancer patients. Hum Mol Genet 5:835-842
20. Dunning AM, Chiano M, Smith NR, et al (1997) Common BRCA 1 variants and susceptibility to breast and ovarian cancer in the general population. Hum Mol Genet 6:285-289
21. Janezic SA, Ziogas A, Krumroy LM, et al (1999) Germline BRCA 1 alterations in a population-based series of ovarian cancer cases. Hum Mol Genet 8:889-897
22. Southey MC, Tesoriero AA, Andersen CR, et al (1999) BRCA 1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer. Br J Cancer, 79:34-39
23. Tommasi S, Crapolicchio A, Lacalamita R, et al (2005) BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy. Mutat Res 578:395-405
24. Hong CC, Thompson HJ, Jiang C, et al (2004) Association between the T27C polymorphism in the cytochrome P450 c17alpha (CYP17) gene and risk factors for breast cancer. Breast Cancer Res Treat: 88:217-230
25. Lee KM, Choi JY, Park SK, et al (2005) Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:821-825
26. Cox DG, Kraft P, Hankinson SE, Hunter DJ (2005) Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer. Breast Cancer Res 7:R171-R175